Chardan Capital assumed coverage on shares of iBio (NYSE:IBIO – Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $5.00 price target on the stock. Separately, StockNews.com started coverage on iBio in a research note on Saturday, April 20th. They issued a sell rating for the […]
Shares of Generation Bio Co. (NASDAQ:GBIO – Get Free Report) have received a consensus recommendation of “Hold” from the six analysts that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year price target […]
HC Wainwright restated their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. Other equities research analysts have also issued reports about the stock. Wells Fargo & Company increased their target price on […]
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) Director Van Amstel Arnout Ploos acquired 80,000 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were bought at an average price of $6.20 per share, with a total value of $496,000.00. Following the acquisition, the director now directly owns […]
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Stock analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for Nuvation Bio in a research report issued on Wednesday, May 22nd. HC Wainwright analyst R. Burns anticipates that the company will post earnings per share of ($0.10) for the quarter. HC Wainwright has […]